(Q36309989)

English

Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

Adaptive radiation therapy

0 references

1 reference

based on heuristic

Hodgkin lymphoma

1 reference

based on heuristic

Suzanne L Wolden

4

object named as

Suzanne L Wolden

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Burton E Appel

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Lu Chen

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Allen Buxton

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David C Hodgson

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

James B Nachman

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

27 July 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

59

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1284-1289

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Rituximab in Hodgkin lymphoma: is the target always a hit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Anthracycline associated cardiotoxicity in survivors of childhood cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Nodular lymphocyte-predominant hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Lymphocyte-predominant Hodgkin disease in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

30 September 2017

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

29 June 2018

Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

29 June 2018

Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Second cancers following pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Fertility in males treated for Hodgkins disease with COPP/ABV hybrid

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

The pathology and nomenclature of Hodgkin's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

22 September 2018

Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24258

21 January 2018

Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468707

5 December 2018

Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonality in nodular lymphocyte-predominant Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22847767

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PBC.24258

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36309989&oldid=2186321264"